Moreover, CDCA2 also demonstrated good diagnostic prediction ability (0.9>AUC>0.7) in nine other malignancies, including ACC, DLBC, HNSC, KIRP, PRAD, SKCM, TGCT, THCA, and THYM (S1 Fig). Here, CDCA2 is linked to adrenal cortex carcinoma.